Home > Insider Trading > Filing (0000885590-11-000019)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Valeant Pharmaceuticals International Inc.	VRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1343811	Ann Norma Provencio	C/O 7150 Mississauga Road Mississauga A6 L5N 8M5		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, No Par Value	Acquisiton	2011-03-04	1,000	$39.87	152,432	No	4	P	Direct
Common Stock, No Par Value	Acquisiton	2011-03-04	195	$39.88	152,627	No	4	P	Direct
Common Stock, No Par Value	Acquisiton	2011-03-04	380	$39.88	153,007	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Common Stock held in the reporting person's 401k account.
102,353 of these represent restricted share units ("RSUs") held by the reporting person as compensation for her services on the Board of Directors of the issuer, including 3,423 RSUs received as dividend equivalents as a result of a dividend paid on the common stock, no par value, of Valeant Pharmaceuticals International, Inc. (the "Common Stock") on December 22, 2010.
This amendment is being filed to correct the number of restricted share units/common shares that were reported in the original filing.
Common Stock held in the reporting person's IRA.